Literature DB >> 22684635

Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines.

Tao Cheng1, Xiao-Fei Wang, Yun-Tian Hou, Li Zhang.   

Abstract

Atrial fibrillation (AF) may occur and persist due to atrial remodeling exacerbated by inflammation. However, whether inflammatory cytokines, such as serum amyloid protein A (SAA), are elevated in patients with atrial arrhythmias remains unclear. In a case-control study design, serum levels of inflammatory cytokines SAA, IL-1, IL-6, TNF-α and high-sensitivity C-reactive protein (hsCRP) were compared between 122 patients with AF and 63 non-AF controls. Of 122 AF patients, 48 had lone AF and 74 organic AF; 65 had paroxysmal AF, 36 persistent AF and 21 permanent AF. In unadjusted analyses, the levels of SAA, hsCRP, TNF-αP, IL-1 and IL-6 were significantly higher in AF patients compared to control patients (P<0.01). Patients with permanent and persistent AF had higher serum levels of inflammatory cytokines than those with paroxysmal AF; all AF patients had higher serum levels than controls (P<0.05). Using a multivariate logistic regression analysis, we found that SAA (OR 3.11; 95% CI, 1.12-6.05), hsCRP (OR 2.53; 95% CI, 1.17-4.38), TNF-α (OR 1.80; 95% CI, 1.03-3.20) and IL-6 (OR 1.21; 95% CI, 0.68-2.87) were correlated with AF (P<0.05). SAA and related inflammatory cytokines are elevated in AF patients. This study is the first to document elevated SAA in AF patients. Although the cause of elevated SAA levels in AF patients remains unknown, elevated SAA may reflect an inflammatory state that promotes the occurrence and persistence of AF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684635     DOI: 10.3892/mmr.2012.934

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  15 in total

Review 1.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.

Authors:  Abhishek Bose; Quynh A Truong; Jagmeet P Singh
Journal:  J Interv Card Electrophysiol       Date:  2015-02-27       Impact factor: 1.900

Review 3.  The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis.

Authors:  Jiwen Fan; Meng Ren; Binay Kumar Adhikari; Haodong Wang; Yuquan He
Journal:  J Inflamm Res       Date:  2022-07-07

Review 4.  Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.

Authors:  Giacomo Emmi; Maria Letizia Urban; Massimo Imazio; Marco Gattorno; Silvia Maestroni; Giuseppe Lopalco; Luca Cantarini; Domenico Prisco; Antonio Brucato
Journal:  Curr Cardiol Rep       Date:  2018-06-14       Impact factor: 2.931

5.  Acute effect of zoledronic acid on the risk of cardiac dysrhythmias.

Authors:  Cristiana Cipriani; Claudia Castro; Mario Curione; Sara Piemonte; Federica Biamonte; Claudio Savoriti; Jessica Pepe; Federica De Lucia; Carolina Clementelli; Luciano Nieddu; Salvatore Minisola
Journal:  Intern Emerg Med       Date:  2014-09-05       Impact factor: 3.397

6.  Inflammation as a Mediator of the Association Between Race and Atrial Fibrillation: Results from the Health, Aging, and Body Composition Study.

Authors:  Thomas A Dewland; Eric Vittinghoff; Tamara B Harris; Jared W Magnani; Yongmei Liu; Fang-Chi Hsu; Suzanne Satterfield; Christina Wassel; Gregory M Marcus
Journal:  JACC Clin Electrophysiol       Date:  2015-06-22

7.  Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.

Authors:  Chunxia Yao; Tina Veleva; Larry Scott; Shuyi Cao; Luge Li; Gong Chen; Prince Jeyabal; Xiaolu Pan; Katherina M Alsina; Issam Abu-Taha; Shokoufeh Ghezelbash; Corey L Reynolds; Ying H Shen; Scott A LeMaire; Wilhelm Schmitz; Frank U Müller; Ali El-Armouche; N Tony Eissa; Christine Beeton; Stanley Nattel; Xander H T Wehrens; Dobromir Dobrev; Na Li
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

8.  NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.

Authors:  Larry Scott; Anke C Fender; Arnela Saljic; Luge Li; Xiaohui Chen; Xiaolei Wang; Dominik Linz; Jilu Lang; Mathias Hohl; Darragh Twomey; Thuy T Pham; Rodrigo Diaz-Lankenau; Mihail G Chelu; Markus Kamler; Mark L Entman; George E Taffet; Prashanthan Sanders; Dobromir Dobrev; Na Li
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

Review 9.  The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation.

Authors:  Xiaolei Wang; Xiaohui Chen; Dobromir Dobrev; Na Li
Journal:  Pflugers Arch       Date:  2021-01-28       Impact factor: 3.657

10.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.